Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer’s disease

Human β-amyloid (Aβ) is believed to be one of the main components of Alzheimer’s disease, so reduction of Aβ is considered a key therapeutic target. Using Agrobacterium-mediated nuclear transformation, we generated transgenic tomatoes for Aβ with tandem repeats. Integration of the human Aβ gene into the tomato genome and its transcription were detected by PCR and Northern blot, respectively. Expression of the Aβ protein was confirmed by western blot and ELISA, and then the transgenic tomato line expressing the highest protein level was selected for vaccination. Mice immunized orally with total soluble extracts from the transgenic tomato plants elicited an immune response after receiving a booster. The results indicate that tomato plants may provide a useful system for the production of human Aβ antigen.

[1]  Young Ho Kim,et al.  Transgenic potato expressing Aβ reduce Aβ burden in Alzheimer's disease mouse model , 2005 .

[2]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[3]  I. Mook‐Jung,et al.  Expression of human β-amyloid peptide in transgenic potato , 2003 .

[4]  J. Hardy,et al.  Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease , 2000, Nature.

[5]  F. Skoog,et al.  A revised medium for rapid growth and bio assays with tobacco tissue cultures , 1962 .

[6]  A. Xiong,et al.  Expression of the Human Hepatitis B Virus Large Surface Antigen Gene in Transgenic Tomato Plants , 2007, Clinical and Vaccine Immunology.

[7]  J. Howard,et al.  Plant molecular farming: systems and products , 2004, Plant Cell Reports.

[8]  K. Fischbeck,et al.  Toxic Proteins in Neurodegenerative Disease , 2002, Science.

[9]  N. Xia,et al.  Expression of ORF2 partial gene of hepatitis E virus in tomatoes and immunoactivity of expression products. , 2003, World journal of gastroenterology.

[10]  M. Estes,et al.  Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  E. Pahlich,et al.  A rapid DNA isolation procedure for small quantities of fresh leaf tissue , 1980 .

[12]  Increased yield of heterologous viral glycoprotein in the seeds of homozygous transgenic tobacco plants cultivated underground. , 2003, Genome.

[13]  C. Arntzen,et al.  Production of hepatitis B surface antigen in transgenic plants for oral immunization , 2000, Nature Biotechnology.

[14]  C. Arntzen,et al.  Oral immunization with hepatitis B surface antigen expressed in transgenic plants , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Frary,et al.  Efficiency and Stability of High Molecular Weight DNA Transformation: an Analysis in Tomato , 2001, Transgenic Research.

[16]  M. Levine,et al.  Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato , 1998, Nature Medicine.

[17]  P. Sojikul,et al.  A plant signal peptide–hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  L. Guoqing.  Immunotherapy for Alzheimers disease , 2006 .

[19]  R. Motter,et al.  Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.

[20]  D. Bosch,et al.  Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B. , 2001, Vaccine.

[21]  S. Castiglione,et al.  Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives. , 2003, Vaccine.